Medical Board of California Seal

Mission

The mission of the Medical Board of California is to protect healthcare consumers and prevent harm through the proper licensing and regulation of physicians and surgeons and certain allied healthcare professionals and through the vigorous, objective enforcement of the Medical Practice Act, and to promote access to quality medical care through the Board's licensing, policy, and regulatory functions.

 Learn More About the Board

File a Complaint

Learn more about the complaint review process and how to file a complaint.

Latest News

The Controlled Substance Utilization Review and Evaluation System (CURES) fee will increase from $9 to $15 annually for licenses expiring on and after July 1, 2025. The fee is assessed at the time of license renewal on licensees that are authorized to prescribe, order, administer, or furnish Schedule II, Schedule III, Schedule IV, or Schedule V controlled substances.

Most licensees will see a $30 CURES fee due to the biennial renewal cycle. The fee covers the reasonable regulatory costs of the Department of Justice for operating and maintaining CURES, a critical element in the state’s continued effort to address the danger of opioid addiction stemming from prescription drug abuse.

For more information about CURES, visit: https://oag.ca.gov/cures.


Effective January 1, 2025, the Research Psychoanalyst Program will be transferred to the Board of Psychology

 11/6/2024

Effective January 1, 2025, the Medical Board of California will transfer the Research Psychoanalyst Program to the Board of Psychology (BOP) under Senate Bill 815, which became law in 2023. At that time, BOP will assume all regulatory responsibility for the program.

This change will not immediately impact your existing registration or practice authority. BOP is considering specific law changes that may interest you. These proposals were discussed at a public meeting on September 20, 2024. To review them, visit www.psychology.ca.gov, select the "Board Meetings" link under "Quick Hits," and scroll down to the Research Psychoanalyst Ad hoc Committee section.

Starting January 1, 2025, please direct all inquiries relating to the Research Psychoanalyst Program to BOP at 916-574-7720, toll-free at 866-503-3221, or Contact BOP via our contact form.


Kimberly Kirchmeyer

Director

Kimberly Kirchmeyer

Department of Consumer Affairs

Reji Varghese

Executive Director

Reji Varghese

Medical Board of California